153 related articles for article (PubMed ID: 9342227)
1. The effects of high salt concentrations on the regulation of the substrate specificity of human recombinant deoxycytidine kinase.
Usova EV; Eriksson S
Eur J Biochem; 1997 Sep; 248(3):762-6. PubMed ID: 9342227
[TBL] [Abstract][Full Text] [Related]
2. A pre-steady-state kinetic analysis of substrate binding to human recombinant deoxycytidine kinase: a model for nucleoside kinase action.
Turk B; Awad R; Usova EV; Björk I; Eriksson S
Biochemistry; 1999 Jun; 38(26):8555-61. PubMed ID: 10387103
[TBL] [Abstract][Full Text] [Related]
3. Identification of residues involved in the substrate specificity of human and murine dCK.
Usova EV; Eriksson S
Biochem Pharmacol; 2002 Dec; 64(11):1559-67. PubMed ID: 12429345
[TBL] [Abstract][Full Text] [Related]
4. Hydrodynamic and spectroscopic studies of substrate binding to human recombinant deoxycytidine kinase.
Mani RS; Usova EV; Eriksson S; Cass CE
Nucleosides Nucleotides Nucleic Acids; 2003 Feb; 22(2):175-92. PubMed ID: 12744604
[TBL] [Abstract][Full Text] [Related]
5. 2 cloning and expression of mouse deoxycytidine kinase. Pure recombinant mouse and human enzymes show differences in substrate specificity.
Karlsson A; Johansson M; Eriksson S
J Biol Chem; 1994 Sep; 269(39):24374-8. PubMed ID: 7929097
[TBL] [Abstract][Full Text] [Related]
6. Differences in kinetic properties of pure recombinant human and mouse deoxycytidine kinase.
Johansson M; Karlsson A
Biochem Pharmacol; 1995 Jul; 50(2):163-8. PubMed ID: 7632159
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase.
Zhu C; Johansson M; Permert J; Karlsson A
Biochem Pharmacol; 1998 Oct; 56(8):1035-40. PubMed ID: 9776315
[TBL] [Abstract][Full Text] [Related]
8. Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analogues .
Hazra S; Ort S; Konrad M; Lavie A
Biochemistry; 2010 Aug; 49(31):6784-90. PubMed ID: 20614893
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide specificity of human deoxycytidine kinase.
Shewach DS; Reynolds KK; Hertel L
Mol Pharmacol; 1992 Sep; 42(3):518-24. PubMed ID: 1406603
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells.
Amsailale R; Van Den Neste E; Arts A; Starczewska E; Bontemps F; Smal C
Biochem Pharmacol; 2012 Jul; 84(1):43-51. PubMed ID: 22490700
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for substrate promiscuity of dCK.
Sabini E; Hazra S; Ort S; Konrad M; Lavie A
J Mol Biol; 2008 May; 378(3):607-21. PubMed ID: 18377927
[TBL] [Abstract][Full Text] [Related]
12. Structures of human deoxycytidine kinase product complexes.
Soriano EV; Clark VC; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2007 Dec; 63(Pt 12):1201-7. PubMed ID: 18084067
[TBL] [Abstract][Full Text] [Related]
13. Deoxynucleoside phosphorylating enzymes in monkey and human tissues show great similarities, while mouse deoxycytidine kinase has a different substrate specificity.
Habteyesus A; Nordenskjöld A; Bohman C; Eriksson S
Biochem Pharmacol; 1991 Oct; 42(9):1829-36. PubMed ID: 1657002
[TBL] [Abstract][Full Text] [Related]
14. Lack of enantiospecificity of human 2'-deoxycytidine kinase: relevance for the activation of beta-L-deoxycytidine analogs as antineoplastic and antiviral agents.
Verri A; Focher F; Priori G; Gosselin G; Imbach JL; Capobianco M; Garbesi A; Spadari S
Mol Pharmacol; 1997 Jan; 51(1):132-8. PubMed ID: 9016355
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence energy transfer studies of human deoxycytidine kinase: role of cysteine 185 in the conformational changes that occur upon substrate binding.
Mani RS; Usova EV; Cass CE; Eriksson S
Biochemistry; 2006 Mar; 45(11):3534-41. PubMed ID: 16533034
[TBL] [Abstract][Full Text] [Related]
16. Casein kinase 1delta activates human recombinant deoxycytidine kinase by Ser-74 phosphorylation, but is not involved in the in vivo regulation of its activity.
Smal C; Vertommen D; Amsailale R; Arts A; Degand H; Morsomme P; Rider MH; Neste EV; Bontemps F
Arch Biochem Biophys; 2010 Oct; 502(1):44-52. PubMed ID: 20637175
[TBL] [Abstract][Full Text] [Related]
17. Human deoxycytidine kinase as a deoxyribonucleoside phosphorylase.
Usova E; Maltseva T; Földesi A; Chattopadhayaya J; Eriksson S
J Mol Biol; 2004 Dec; 344(5):1347-58. PubMed ID: 15561147
[TBL] [Abstract][Full Text] [Related]
18. Extending thymidine kinase activity to the catalytic repertoire of human deoxycytidine kinase.
Hazra S; Sabini E; Ort S; Konrad M; Lavie A
Biochemistry; 2009 Feb; 48(6):1256-63. PubMed ID: 19159229
[TBL] [Abstract][Full Text] [Related]
19. The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation.
Zhang Y; Secrist JA; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):133-9. PubMed ID: 16421443
[TBL] [Abstract][Full Text] [Related]
20. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
